FMS Q2 2023 Earnings Report — Fresenius Medical Care AG & Co. KGaA Revenue & Financial Results | Market Cap Arena

Fresenius Medical Care AG & Co. KGaAFMS

Q2 2023 Earnings

Reported June 30, 2023

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2023	Q1 2023	Q2 2022	QoQ Change	YoY Change
Revenue	$5.6B	—	$5.6B	—	1.4%
Op. Income	$417M	—	$398M	—	4.8%
Gross Margin	24.8%	—	26.2%	—	-1.4pp
Net Margin	2.9%	—	3.1%	—	-0.2pp
EPS (Diluted)	$0.19	—	$0.15	—	23.1%
Free Cash Flow	$996M	—	$677M	—	47.0%

Revenue Flow

Item	Amount
REVENUE	$5.6B
Cost of Revenue	$4.2B
GROSS PROFIT	$1.4B
R&D Expenses	$67M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$906M
Other Expenses	$9M
Operating Expenses	$982M
Cost & Expenses	$5.2B
OPERATING INCOME	$417M
Interest Income	$28M
Interest Expense	$123M
Other Income/Expenses	-$95M
INCOME BEFORE TAX	$323M
Income Tax Expense	$95M
Net Income from Continuing Ops	$228M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$164M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$164M
D&A	$507M
EBIT	$445M
EBITDA	$953M
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$5.6B
Cost of Revenue	$4.2B
GROSS PROFIT	$1.4B
R&D Expenses	$67M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$906M
Other Expenses	$9M
Operating Expenses	$982M
Cost & Expenses	$5.2B
OPERATING INCOME	$417M
Interest Income	$28M
Interest Expense	$123M
Other Income/Expenses	-$95M
INCOME BEFORE TAX	$323M
Income Tax Expense	$95M
Net Income from Continuing Ops	$228M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$164M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$164M
D&A	$507M
EBIT	$445M
EBITDA	$953M
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$164M
Depreciation & Amortization	$444M
Stock-Based Compensation	$0
Deferred Income Tax	$0
Other Non-Cash Items	$132M
Change in Working Capital	$438M
OPERATING CASH FLOW	$1.2B
Capital Expenditure	-$182M
Acquisitions (Net)	-$12M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$38M
NET CASH FROM INVESTING	-$156M
Net Debt Issuance	-$604M
Common Stock Repurchased	$0
Common Dividends Paid	-$384M
Other Financing Activities	$167M
NET CASH FROM FINANCING	-$821M
FREE CASH FLOW	$996M
Net Change in Cash	$161M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.6B
Short-Term Investments	$0
Net Receivables	$4.3B
Inventory	$2.7B
Other Current Assets	$1.2B
TOTAL CURRENT ASSETS	$9.8B
PP&E (Net)	$9.3B
Goodwill	$18.0B
Intangible Assets	$1.6B
Long-Term Investments	$814M
Tax Assets	$0
Other Non-Current Assets	$1.4B
TOTAL NON-CURRENT ASSETS	$31.1B
TOTAL ASSETS	$40.9B
Account Payables	$958M
Short-Term Debt	$1.9B
Deferred Revenue	$0
Other Current Liabilities	$3.9B
TOTAL CURRENT LIABILITIES	$7.7B
Long-Term Debt	$8.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.0B
Other Non-Current Liabilities	$2.0B
TOTAL NON-CURRENT LIABILITIES	$15.7B
TOTAL LIABILITIES	$23.4B
Common Stock	$343M
Additional Paid-In Capital	$3.9B
Retained Earnings	$12.4B
Treasury Stock	$0
Accum. Other Comp. Income	-$911M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$15.8B
Minority Interest	$1.6B
TOTAL EQUITY	$17.5B
TOTAL LIABILITIES & EQUITY	$40.9B
Total Debt	$15.3B
Net Debt	$13.7B